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Objectives. Chronic cough is a multifactorial symptom that requires multidisciplinary approach. Over the last years, general
practitioners refer increasingly more chronic cough patients directly to the otolaryngologist. The aim of this paper is to highlight
theissuesindiagnosisandmanagementofchroniccoughpatientsfromtheotolaryngologistperspective.Design.Literaturereview.
Results. Gastroesophageal reﬂux and postnasal drip syndrome remain one of the most common causes of chronic cough. Better
diagnostic modalities, noninvasive tests, and high technology radiological and endoscopic innovations have made diagnosis of
these diﬃcult-to-treat patients relatively easier. Multidisciplinary assessment has also meant that at least some of these cases can be
dealt with conﬁdently in one stop clinics. Conclusions. As the number of referrals of chronic cough patients to an Ear Nose Throat
Clinic increases, the otolaryngologist plays a pivotal role in managing these diﬃcult cases.
1.Introduction
Chronic cough is a persistent and frustrating symptom for
many adults and children and a frequent reason for primary
or secondary care visits or referrals. This condition generates
signiﬁcant healthcare and economic cost and is associated
withaspectrumofdisordersacrossmultiplemedicalspecial-
ties and can provide signiﬁcant challenges for the involved
physician or surgeon. Chronic cough is associated with dete-
rioration in the quality of patients’ lives. Associated symp-
toms and negative outcomes with this condition include loss
of sleep, exhaustion, irritability, urinary incontinence, cough
syncope,socialdisability,andinabilitytoperformdailyactiv-
ities. Many patients experience chronic cough secondary to
another medical condition, such as COPD, asthma, rhinos-
inusitis, Gastroesophageal reﬂux syndrome (GERD), postn-
asal drip syndrome (PNDS), or unknown etiology. GERD is
thought to be the most common cause of chronic cough in
a nonsmoker nonasthmatic individual.
Thorough assessment of a patient with a chronic cough
relies on a multidisciplinary approach. The otolaryngologist
should be familiar with the diagnostic algorithm of chronic
cough patients and should work closely with the gastroen-
terologist and the pulmonologist, ideally in “cough clinics,”
to conﬁdently diagnose and treat these patients.
1.1. Reﬂux and Chronic Cough. Chronic nonspeciﬁc cough,
deﬁned as a nonproductive cough in the absence of identi-
ﬁable respiratory disease or known cause [1] persisting for
morethanthreetoeightweeks[2],posesasigniﬁcantburden
to healthcare costs and considerably impairs quality of life.
Gastroesophageal reﬂux disease (GERD) represents one of
the three main causes of chronic cough (along with asthma
and upper airways cough/postnasal drip syndrome), impli-
catedinupto41%ofchroniccoughpatients[3].Theclinical
features of GERD-related cough include heartburn, regurgi-
tation,and/orworseningofcoughafterfoodsormedications
known to decrease lower esophageal sphincter-pressure,
with extraesophageal manifestations such as hoarseness,
wheezing, sore throat, chest pain, and globus also described.
Whilst classic GERD symptoms are present in 6–10% of
chronic cough patients, GERD is clinically silent in up to2 International Journal of Otolaryngology
75% of patients with GERD-related cough [4]. Diagnosis of
GERD is frequently based on the clinical responses of cough
to antireﬂux therapy rather than on objective assessments of
GERD per se. Furthermore, an increased understanding of
the pathophysiology of GERD and in particular the speciﬁc
phenomenon of laryngopharyngeal reﬂux (LPR), has high-
lightedthecomplexityofthiscondition,withtheneedforin-
dividual patients assessment and tailoring of therapy becom-
ing apparent.
Coughing may be provoked by reﬂux via a number of
mechanisms. The regurgitation of gastric contents into the
laryngopharynx can cause mechanical or pH-sensitive stim-
ulation, with chronic inﬂammation leading to the sensitisa-
tionofperipheralnervesmediatingcough[5].Thismayhave
an acid or nonacid (namely, bile and pepsin) basis. Adha-
mi et al. [6] demonstrated that bile can injure the laryngeal
epithelium but only in an acidic environment, and further-
more, Sasaki et al. [7] were able to demonstrate histological
laryngeal injury in a rat model following bile exposure
in neutral environments. Pepsin, the principal proteolytic
enzyme of the stomach, is predominantly active in acidic pH
andhasbeenshowntocauselaryngealinjuryinthisstate[6];
however proteolytic activity is still present up to pH 7 and
can be reactivated [8]. Johnston et al. [8] found the presence
of pepsin in the larynx of patients with the clinical diagnosis
of LPR but not in controls and in these same patients, pepsin
was absent in their esophageal epithelium [9]. It has been
suggested that coughing can also be induced by “micro” or
“silent” aspiration, caused by the direct activation of trach-
eo-bronchial receptors by reﬂux entering the airway. Distal
esophageal reﬂux may also induce coughing through vagal
stimulation known as the oesophago-bronchial reﬂex [10],
Ing et al. [11], demonstrating that infusing acid into the
oesophagus of chronic cough patients increases coughing.
Additionally whilst infusion of acid (compared to saline)
into the oesophagus of those GERD patients without chronic
coughhadnoeﬀect,asensitisedcoughreﬂextocapsaicinwas
seen in those GERD patients with chronic cough [12].
An alternative pathophysiology is that coughing can in
fact be the causation in reﬂux: increased intra-abdominal
pressure during strenuous coughing episodes negatively
impacting the lower esophageal sphincter, possibly by way of
a positive feedback loop [13].
As discussed above, reﬂux associated cough can be a
laryngopharyngeal or distal esophageal phenomena. LPR has
distinct features, as ﬁrst identiﬁed by Koufman and collea-
gues. In a combined reported series of 899 patients, throat
clearing was a complaint of 87% of LPR patients versus 3%
of those with GERD, while only 20% of LPR patients com-
plainedofheartburnversus83%intheGERDgroup[5].Dif-
ferences in body mass index (BMI) between GERD and LPR
patients have also been highlighted; in a retrospective study
of500patientsattendingforpHprobestudies,themeanBMI
of isolated LPR patients was 25.9 compared to 28.3 for those
with GERD [14].
Identifying GERD as the cause of a chronic cough can
be challenging. Esophageal pH testing can demonstrate an
increased number of reﬂux events, prolonged exposure of
the esophageal mucosa to reﬂux, or more convincingly a
signiﬁcant temporal association between reﬂux events and
cough. Although esophageal pH testing has a sensitivity of
approximately 90% for the evaluation of chronic cough,
speciﬁcity ranges from 66% to 100% [15, 16]. Addi-
tional diagnostic tests include inhaled tussigenic challenges,
endoscopy, examining bronchoalveolar lavage ﬂuid, and/or
sputum for lipid laden macrophages, barium swallow, Bern-
stein test, radioisotope scintiscan, and radionucleotide emp-
tying studies with solids [17]. Examination of the larynx
may reveal evidence of LPR: key examination ﬁndings being
vocal cord oedema and erythema as well as medial vocal
cord erythema [18, 19]. Findings should, however, be taken
in context: Hicks and colleagues ﬁnding that almost 80% of
study participants had a least one reﬂux-attributable ﬁnding
onlaryngoscopywhen100healthyvolunteerswereexamined
[20].
1.2. Treatment of GERD-Associated Cough. Patient counsell-
ing is essential in reducing GERD and related LPR. Dietary
advice includes the avoidance of a high-fat diet and losing
weight if obese, avoiding eating two hours before bedtime
andrefrainingfromcaﬀeine,carbonateddrinks,alcohol,and
citrus products [21]. Patients should also be asked to refrain
fromsmokingandelevatetheheadofthebedby15cm.Some
medications are associated with increase GERD, namely,
anticholinergics, beta-agonists, bisphosphonates, calcium-
channel blocker, corticosteroids, benzodiazepines, oestro-
gens,opiates,progesterone,prostaglandins,andtheophylline
[17]. Other recommendations include nasal continuous
positive airway pressure if obstructive sleep apnoea is present
[22]andavoidingexercisethatmayincreaseintra-abdominal
pressure [23].
Proton pump inhibitors (PPIs) have commonly been
the mainstay empirical treatment for GERD-related cough.
Given the diﬃculty in clearly diagnosing this condition,
Irwin [21] has described the clinical proﬁle of such patients
in whom empirical therapy should be considered; those not
exposedtoenvironmentalirritants,notapresentsmoker,not
on an ACE inhibitor, with a normal/stable chest radiograph,
and in whom symptomatic asthma, upper airways cough sy-
ndrome, and nonasthmatic eosinophilic bronchitis has been
ruled out. The use of empirical therapy has, however, been
questioned. In a meta-analysis of 5 randomised controlled
trials on GERD treatment for cough in adults and children
without primary lung disease, Chang et al. [24] found that
there was no diﬀerence in cough resolution for patients who
received a placebo versus a PPI (OR 0.24 (95% CI 0.04 to
1.27). There was, however, a signiﬁcant diﬀerence in second-
aryoutcomesofmeancoughscore(meandiﬀerenceof −0.51
(−1.02 to 0.01)) and change in cough score (−0.29 (−0.62
to 0.04)) at the end of the trial. This led the authors to
concludethattheuseofPPIhad“someeﬀectinsomeadults.”
More recently, a Cochrane Database Systematic review by
Chang and colleagues [2] including 9 randomised controlled
trials of PPIs for adults with chronic cough found that using
intention-to-treat, pooled data from studies resulted in no
signiﬁcant diﬀerence between treatment and placebo in total
resolution of cough (OR 0.46; 95% CI 0.19 to 1.15 no overall
signiﬁcant improvement in cough outcomes (end of trial orInternational Journal of Otolaryngology 3
change in cough scores). There was, however, a signiﬁcant
improvement in cough scores at end of intervention (two
to three months) in those receiving PPI (standardised mean
diﬀerence −0.41; 95% CI −0.75 to −0.07) using generic
inverse variance analysis on cross-over trials. The authors
were unable to conclude deﬁnitely that GERD treatment
with PPIs is universally beneﬁcial for cough associated with
GERD.Despite the current lack ofevidencefordeﬁnite treat-
ment of empiric treatment, published guidelines from the
ACCP [21]a n dB T S[ 25] suggest that PPI therapy should be
commenced, for example, omeprazole 20–40mg twice daily
or equivalent taken before meals for at least 8 weeks [25].
Of particular interest in nonacidic refux, medications
suchasGavisconorGavisconAdvance,whichactbyforming
a raft or physical barrier to reﬂux present a supplementary or
evenalternativetreatmentoption.McGlashanetal.[26]c on-
ducted a randomised controlled trial of Gaviscon Advance
in 49 patients with a diagnosis LPR (based on the reﬂux
symptom index (RSI) and the reﬂux ﬁndings score (RFS)).
Patientswereassessedpretreatmentandat2,4,and6months
after treatment. Signiﬁcant diﬀerences in the mean (SD)
between treatment and control were observed for RSI at the
2-month (11.2 (7.0) versus 16.8 (6.4), P = 0.005) and 6-
month (11.2 (8.1) versus 18.3 (9.4), P = 0.008) assessments
and for RFS at the 6-month (7.1 (2.8) versus 9.5 (3.4), P =
0.005)assessment.Thedetailsofthecoughcomponentofthe
RSI were not, however, detailed further in the report.
Gastroesophageal dysmotility has been implicated in the
pathophysiology of GERD via abnormalities of delayed gas-
tric emptying and reduced pressure or inappropriate transi-
ent relaxation of the lower esophageal sphincter [27]. Several
prokinetic agents (e.g., bethanechol, metoclopramide, dom-
peridone, cisapride, and macrolides such as erythromycin)
can stimulate gastrointestinal motility and have, therefore,
been proposed as useful adjuncts to antireﬂux medication.
The evidence base for this lies only in unblinded, uncon-
trolled studies, where,when in combination PPIs for treating
GERD-associated cough, cough or hoarseness improved by
70% to 100% [10, 28–31]. In the recent Cochrane review,
Chang et al. [2] found insuﬃcient data to evaluate the
evidence for the use of prokinetic agents in chronic cough.
However, interestingly in 56 patients diagnosed with GERD-
r e l a t e dc o u g h ,2 4r e s p o n d e dt oaP P Ia l o n e ;h o w e v e r ,1 8o f
theremainingpatientsimprovedwiththeadditionofmetoc-
lopramide or cisapride [32]. These drugs, however, may have
signiﬁcant side-eﬀects: erythromycin, for example, often
causes nausea and abdominal pain and cisapride was with-
drawn from the US market due to safety concerns.
Although surgery is more traditionally used to treat the
more typical reﬂux symptoms, it may be of some value in
the management of reﬂux-related cough. Studies relating to
the outcomes of surgical treatment of GERD are, however, of
questionable value as they suﬀer from lack of controls and
blinding, use diﬀering postoperative evaluation criteria, and
are typically based on a highly selective group of patients.
Kaufman and colleagues [33] reported their long-term
(mean53months)outcomesof128patientstreatedwithlap-
aroscopic antireﬂux surgery. Cough and hoarseness was im-
proved in 65% to 75% of cases compared to heartburn and
regurgitation in over 90% of subjects. In their review of
treatment options for GERD-related cough, Chandra and
Harding [17] summarised the ﬁnding of 9 prospective stud-
ies of surgical management, reporting that 586 of 689 sur-
gically treated patients had a “signiﬁcant cough response.”
GERD remains one of the leading causes of chronic
cough; however, the diﬃculty in diagnosing this condition,
especially as “classic” reﬂux symptoms are often absent
means that it can be overlooked. The mainstay of treatment,
for now, remains as lifestyle modiﬁcation, dietary advice,
and medical therapy. The role of traditional empirical treat-
ment with PPIs is questionable, with evidence from ran-
domisedtrialsimplyingthatthereissomebeneﬁtintheright
patient group. Identifying this patient group is, therefore,
imperative: careful clinical history taking and laryngeal eval-
uation along with objective reﬂux assessment being key. The
use of alginate preparations seems to be quite popular in the
last few years, although evidence is currently lacking. Sur-
gical management, although not as useful for cough symp-
tomatology as for classic symptoms also has a role in patients
resistant to medical therapy.
2. PostnasalDripSyndrome
(or Upper AirwayCough Syndrome)
Postnasal drip (PND) or catarrh is the drainage of secretions
from the nose or paranasal sinuses into the pharynx. Clini-
cally, the diagnosis of PND syndrome (PNDS) is very vague,
made on history and examination and relies on the reporting
of the patient of this sensation of something “dripping down
the throat,” rhinorrhoea and constant throat clearing [34].
Nasendoscopy revealing rhinitis and mucopurulent secre-
tions is suggestive, although not diagnostic. The issues when
attempting to diagnose PNDS, is that there are no objective
sensitive or speciﬁc tests and no way to quantify the amount
ofcatarrhortoprovethatitisdirectlyresponsibleforcausing
cough. PNDS is associated with very nonspeciﬁc symptoms
and a deﬁnitive diagnosis of PND-induced cough cannot be
made from the history and examination ﬁndings alone.
The diﬀerential diagnosis of PNDS-induced cough
includes all other causes of rhinitis including, allergic rhini-
tis, perennial nonallergic rhinitis, bacterial sinusitis, allergic
fungal sinusitis, rhinitis due to anatomic sinonasal abnor-
malities, rhinitis due to physical or chemical irritants, occup-
ational rhinitis, rhinitis medicamentosa, and rhinitis of pre-
gnancy.
Another issue when attempting to diagnose PNDS-
induced cough is that GERD is often associated with a high
prevalence of upper respiratory symptoms and therefore can
either coexist or mimic PNDS [35]. The introduction of the-
more widely accepted in Americas-term of “Upper Airway
Cough Syndrome” (UACS) was made based on the need to
answer the question whether “the conditions listed above
actually produce cough through a ﬁnal common pathway of
PND or whether, in fact, in some circumstances they cause
irritation or inﬂammation of upper airway structures that
directlystimulatecoughreceptorsandproducecoughindep-
endently of or in addition to any associated PND” [35].4 International Journal of Otolaryngology
It is obvious that because there are no objective tests for
diagnosing PND, treatment is often based on the speciﬁc
disease that is present. For example, avoidance of speciﬁc al-
lergensafterallergytestinghasbeendone,nasalsteroidtreat-
ment and antihistamines, treatment of concomitant infec-
tion, and correction of any associated sinonasal anatomical
abnormalities can have an indirect eﬀect on the management
of PND-induced cough.
The American College of Chest Physicians recommends
an empiric trial of therapy for UACS because improvement
orresolution of coughin response tospeciﬁc treatmentisthe
pivotal factor in conﬁrming the diagnosis of UACS as a cause
of cough. That should especially be the case if no speciﬁc
cause can be elicited from the history and examination [36].
A usual empiric therapy involves a ﬁrst generation anti-
histamine/decongestant. If a patient has resolution or partial
resolution of cough, then UACS is considered to have been
a cause of cough and antihistamine therapy is continued.
Marked improvement or resolution of cough may take seve-
ral weeks and occasionally as long as a few months [37].
If there is no response with a ﬁrst-generation antihis-
tamine, then the patient should undergo sinus imaging. Ch-
ronic sinusitis causes a productive cough or can be clinically
silent, in that the cough can be nonproductive, and none of
the typical ﬁndings associated with acute sinusitis may be
present [36, 38].
Allergy skin testing, measurement of serum Ig levels to
see whether (acquired) hypogammaglobulinemia is present,
evaluation of the patient’s home and workplace if there is
a potential environmental cause for persistent upper air-
way symptom are all reasonable diagnostic strategies espe-
ciallyifthereislackofresponsetosinusitistreatment.Ifnase-
ndoscopy reveals nasal polyps, in the absence of any contra-
indication, the patient should undergo a standard aspirin
challenge. If the results of the challenge are positive, the
patient should undergo desensitization, followed by the
consideration of chronic aspirin therapy unless it is con-
traindicated.
3. Conclusions
Chronic cough can be associated with many diseases that
often overlap more than one medical specialty. A detailed
assessment of the patient with chronic cough relies on a
multidisciplinary approach and close cooperation between
pulmonary medicine, gastroenterology, and otolaryngology.
Gastrooesophageal reﬂux and postnasal drip syndrome
account for a signiﬁcant number of cases of chronic non-
productive cough seen in otolaryngology practice. Each may,
alone or in combinationcontribute to cough even when
clinically silent, and failure to recognise their contribution
may lead to unsuccessful treatment. Many of these patients
are notoriously diﬃcult to diagnose and treat but the liter-
ature suggests that a systematic and thorough approach in a
multidisciplinary setting can lead to successful diagnosis and
treatment in the majority of patients.
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